Marissa A. Brittenham's most recent trade in Surgery Partners Inc was a trade of 3,156 Common Stock done at an average price of $24.1 . Disclosure was reported to the exchange on March 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 24.09 per share. | 10 Mar 2025 | 3,156 | 63,408 (0%) | 0% | 24.1 | 76,028 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 23.80 per share. | 04 Mar 2025 | 10,084 | 60,262 (0%) | 0% | 23.8 | 239,999 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 23.80 per share. | 04 Mar 2025 | 6,302 | 66,564 (0%) | 0% | 23.8 | 149,988 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 25.61 per share. | 07 Feb 2025 | 14,700 | 50,178 (0%) | 0% | 25.6 | 376,467 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 25,110 | 64,878 (0%) | 0% | 0 | Common Stock | |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 30.17 per share. | 04 Mar 2024 | 1,284 | 39,768 (0%) | 0% | 30.2 | 38,738 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 31.18 per share. | 28 Feb 2024 | 7,697 | 41,052 (0%) | 0% | 31.2 | 239,992 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 31.18 per share. | 28 Feb 2024 | 2,886 | 33,355 (0%) | 0% | 31.2 | 89,985 | Common Stock |
Surgery Partners Inc | A. Brittenham Marissa | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 02 Feb 2024 | 1,637 | 30,469 (0%) | 0% | 31.9 | 52,204 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 32.86 per share. | 02 Mar 2023 | 15,216 | 32,106 (0%) | 0% | 32.9 | 499,998 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 32.86 per share. | 02 Mar 2023 | 7,608 | 16,890 (0%) | 0% | 32.9 | 249,999 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 35.90 per share. | 02 Feb 2023 | 1,320 | 9,282 (0%) | 0% | 35.9 | 47,388 | Common Stock |
Surgery Partners Inc | Marissa A. Brittenham | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 44.80 per share. | 01 Feb 2022 | 10,602 | 10,602 (0%) | 0% | 44.8 | 474,970 | Common Stock |